PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Tameside and Glossop Integrated Care NHS Foundation Trust, Fountain Street, Ashton-under-Lyne OL6 9RW, UK.\', \'The University of Manchester, Oxford Road, Manchester M13 9PL, UK.\', \'Royal Preston Hospital, Lancashire Teaching Hospitals NHS Foundation Trust, Sharoe Green Lane, Fulwood, Preston PR2 9HT, UK.\', \'Manchester Metropolitan University, All Saints Building, Oxford Road, Manchester M15 6BH, UK.\', \'Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Infirmary Square, Leicester LE1 5WW, UK.\', \'Leicester General Hospital, University Hospitals of Leicester NHS Trust, Gwendolen Road, Leicester LE5 4PW, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • E379910.3390/nu12123799
?:hasPublicationType
?:journal
  • Nutrients
is ?:pmid of
?:pmid
?:pmid
  • 33322317
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.557
?:rankingScore_hIndex
  • 62
is ?:relation_isRelatedTo_publication of
?:title
  • High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33322317>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33322317>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all